본문 바로가기
KERD
논문KCI 등재

대장균에 의한 요로감염의 연령별, 계통군별 특징

Clinical and Phylogenetic Characteristics of Escherichia coli Urinary Tract Infections

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

목적:E. coli UTI의 임상양상과 UPEC의 미생물학적 특징을 확인하여 연령별, 계통군별 연관성을 평가하고자 하였다. 방법:2008년 9월부터 2009년 8월까지 요로감염으로 입원하여 배양검사에서 E. coli가 검출된 환아를 대상으로 하였다. 환자의 임상양상과 검사소견을 확인하였고, 검출된 E. coli를 계통학적으로 분류하고 독성유전자의 분포와 항생제 내성률을 조사하였다. 결과:총 47명의 E. coli UTI 환아가 연구에 참여하였다. 연령군별로 6개월 미만 30명(63.8%), 6-12개월은 8명(17.0 %), 12개월 이상 9명(19.1%)이었다. 6개월 미만 연령군에는 남아(70.0%)가 많았고 6개월 이상 연령군에는 여아(76.5%)가 많았다(P=0.002). 계통학적 분석에서 UPEC의 대부분(80.8%)은 B2 혹은 D군에 속하였다. 연령군별로는 6개월 미만 연령군에는 B2군(80.0 %)가 많았고 6개월 이상 연령군에는 non-B2군(52.9%)가 많았다(P=0.020). 계통군별로는 B2군에는 몇몇 독성유전자의 높은 분포가 확인되었고(P<0.05), D군에는 TMP/SMX에 내성을 보이는 균주들이 높은 빈도로 포함되었다(P=0.031). 결론:E. coli UTI 환아 중 6개월 미만과 6개월 이상 연령군은 남녀비와 계통군의 분포 차이를 보였다. 즉, 6개월 미만 연령군에는 남아와 B2군의 분포가 높았고, 6개월 이상 연령군에는 여아와 non-B2군의 분포가 높았다. 연령별 계통군의 분포 차이는 향후 연구를 통해 검증이 필요할 것이다.

Abstract

Purpose:We aimed to investigate the clinical and phylogenetic characteristics of Escherichia coli Urinary Tract Infections (E. coli UTI). Methods:We enrolled patients with culture-proven E. coli UTI, who were admitted at the study hospital from September 2008 to August 2009. We investigated clinical data of patients with E. coli UTI and characteristics of isolated E. coli strains. The phylogenetic groups were classified using triplex polymerase chain reaction (PCR), and the distribution of nine virulent genes was determined by multiplex PCR. Results:A total of 47 patients have participated in this study. Thirty (63.8%) were under 6 months; eight (17.0%) were between 6-12 months; and nine (19.1%) were over 12 months. We compared two age groups between under 6-month and over 6-month. In the age group under 6-month, higher proportion of male (P=0.002) and group B2 strains (P=0.020) were observed. In contrast, higher proportion of female and group non-B2 strains were observed in age group over 6- month. Frequencies of papC, papGII, papGIII, sfa/foc, hlyC, cnf1, fyuA, iroN and iucC were estimated as 68.1%, 57.4%, 42.6%, 46.8%, 46.8%, 31.9%, 87.2%, 48.9% and 63.8%, respectively. In the comparison of phylogenetic groups, group B2 showed higher distribution of virulent genes, while group D included more strains resistant to trimethoprim/sulfamethoxazole (TMP/SMZ) than other groups. Conclusion:We showed the age group-specific difference in the distribution of sex ratios and phylogenetic groups; more male and group B2 strains in age group under 6-month, while more female and group non-B2 in age group over 6-month. However, further evaluation including larger number of patients will be necessary to confirm above thesis in future molecular epidemiological studies.

참고문헌 (25)

  1. Shaikh N, "Prevalence of urinary tract infection in childhood: a meta-analysis", Pediatr Infect Dis J, 27, pp.302~308 (2008)
  2. Elder JS, "Urologic disorders in infants and children. In: Nelson Textbook of Pediatrics. 18th ed", pp.2223~2228 (2007), WB Saunders Co
  3. Herz AM, "Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine", Pediatr Infect Dis J, 25, pp.293~300 (2006)
  4. Johnson JR, "Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis", Microbes Infect, 8, pp.1702~1713 (2006)
  5. Duriez P, "Commensal Escherichia coli isolates are phylogenetically distinct human populations", Microbiology, 147, pp.1671~1676 (2001)
  6. Baldy-Chudzik K, "Phylogenetic background, virulence gene profiles, and genomic diversity in commensal Escherichia coli isolated from ten mammal species living in one zoo", Vet Microbiol, 131, pp.173~184 (2008)
  7. Orsi RH, "Identification of Escherichia coli from groups A, B1, B2 and D in drinking water in Brazil", J Water Health, 5, pp.323~327 (2007)
  8. Houdouin V, "Phylogenetic groups and virulence factors of Escherichia coli strains causing pyelonephritis in children with and without urinary tract abnormalities", Clin Microbiol Infect, 13, pp.740~742 (2007)
  9. Herzer PJ, "Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli", J Bacteriol, 172, pp.6175~6181 (1990)
  10. Rijavec M, "High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups", Curr Microbiol, 53, pp.158~162 (2006)
  11. Russo TA, "Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC", J Infect Dis, 181, pp.1753~1754 (2000)
  12. Russo TA, "A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate", Vaccine, 25, pp.3859~3870 (2007)
  13. Durant L, "Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli", Infect Immun, 75, pp.1916~1925 (2007)
  14. Yoo KH, "Characterization of uropathogenic Escherichia coli", Korean J UTII, 2, pp.61~65 (2007)
  15. Cheng CH, "Effective duration of antimicrobial therapy for the treatment of acute lobar nephronia", Pediatrics, 117, pp.84~89 (2006)
  16. Clermont O, "Rapid and simple determination of the Escherichia coli phylogenetic group", Appl Environ Microbiol, 66, pp.4555~4558 (2000)
  17. Le Bouguenec C, "Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction", J Clin Microbiol, 30, pp.1189~1193 (1992)
  18. Johnson JR, "Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise", J Infect Dis, 181, pp.261~272 (2000)
  19. Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Fifth informational supplement, M100-S15", CLSI, ~ (2005)
  20. Johnson JR, "Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli", Int J Med Microbiol, 295, pp.383~404 (2005)
  21. Johnson JR, "Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobialsusceptible clinical isolates of Escherichia coli from across the United States, 2000-2001", J Infect Dis, 190, pp.1739~1744 (2004)
  22. Grude N, "A comparison of phylogenetic group, virulence factors and antibiotic resistance in Russian and Norwegian isolates of Escherichia coli from urinary tract infection", Clin Microbiol Infect, 13, pp.208~211 (2007)
  23. Randolph MF, "Office screening for bacteriuria in early infancy: collection of a suitable urine specimen", J Pediatr, 76, pp.934~936 (1970)
  24. Manges AR, "Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group", N Engl J Med, 345, pp.1007~1013 (2001)
  25. Bingen-Bidois M, "Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains", Infect Immun, 70, pp.3216~3226 (2002)

관련 논문AI추천

이 간행물의 다른 논문 (6건)